Biofrontera Inc. — Director's Dealing 2025

Sep 17, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Biofrontera Inc. (BFRI)
CIK: 0001858685
Period of Report: 2025-07-22

Reporting Person: Luebbert Hermann (Director, CEO & Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-10	Common Stock	M	137500	—	Acquired	152711	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-07-22	Restricted Stock Units	$	A	125000	Acquired		Common Stock (125000)	Direct
2025-07-22	Employee stock option (right to buy)	$1.00	A	125000	Acquired	2035-07-22	Common Stock (125000)	Direct
2025-09-10	Restricted Stock Units	$	M	137500	Disposed		Common Stock (137500)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: Each restricted stock unit represents a contingent right to receive one share of BFRI common stock. The reporting person received the restricted stock units as an award for no consideration.

F3: The restricted stock units vest in two equal yearly installments for the first two years following the grant date, beginning on July 22, 2026. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.

F4: The option vests in two equal semi-annual installments beginning on January 22, 2026.

F5: On July 12, 2024 the reporting person was granted 275,000 restricted stock units, vesting in two equal annual installments beginning on July 12, 2025. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.

F6: Restricted stock units with different terms are not included.

F7: Options with different terms are not included.